Brain resilience

Brain Resilience Postdoctoral Scholar Annie Goettemoeller is studying how epilepsy-like activity might drive the spread of Alzheimer’s pathology in the brain

Neuroscientists studying inflammation and age-related brain decline engineered a protein that spurs the growth of new neurons in aging mice

Researchers from around the world convened at Stanford to present their latest work on neurodegeneration and brain resilience

Proteins that start life inside neurons build up faster in old age and spread to other brain cells—a potential source of neurological mischief

From studying post-viral fatigue to engineering transparent mouse brains, round three of the Wu Tsai Neurosciences Institute’s Big Ideas grants will push the bounds of what’s possible

Everything we know now, and what we hope and pray is coming

Neuroradiologist Raag Airan and his lab have found a non-invasive, drug-free method to help clean the brain, reduce inflammation, and treat disease—and with Knight Initiative for Brain Resilience support, they plan to test it in people soon.

The Knight Initiative’s Fall Symposium featured researchers building new molecular atlases of the brain alongside new updates on neurodegenerative disease and what might be done about it.

Amyloid plaques have long been the focus of Alzheimer’s therapies. But Wu Tsai Neuro's Emmanuel Mignot and others are focusing on the stringy tangles of a protein called tau, the unsung second hallmark of Alzheimer’s.

Scientists including Knight Initiative Director Tony Wyss-Coray are trying to find out whether plasma can slow aging.